{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,7]],"date-time":"2026-09-07T11:24:40Z","timestamp":1788780280562,"version":"build-2803163510"},"reference-count":76,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","theclinics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinics in Liver Disease"],"published-print":{"date-parts":[[2024,2]]},"DOI":"10.1016\/j.cld.2023.06.006","type":"journal-article","created":{"date-parts":[[2023,8,12]],"date-time":"2023-08-12T00:55:55Z","timestamp":1691801755000},"page":"79-92","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":24,"title":["Primary Biliary Cholangitis"],"prefix":"10.1016","volume":"28","author":[{"given":"Inbal","family":"Houri","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gideon M.","family":"Hirschfield","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.cld.2023.06.006_bib1","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1007\/s00281-018-0715-8","article-title":"Sex-related factors in autoimmune liver diseases","volume":"41","author":"Schwinge","year":"2019","journal-title":"Semin Immunopathol"},{"issue":"4","key":"10.1016\/j.cld.2023.06.006_bib2","doi-asserted-by":"crossref","first-page":"936","DOI":"10.1111\/jgh.15214","article-title":"Extrahepatic autoimmune diseases in primary biliary cholangitis: prevalence and significance for clinical presentation and disease outcome","volume":"36","author":"Efe","year":"2021","journal-title":"J\u00a0Gastroenterol Hepatol"},{"issue":"1","key":"10.1016\/j.cld.2023.06.006_bib3","doi-asserted-by":"crossref","first-page":"23","DOI":"10.3109\/08916939709009547","article-title":"Primary biliary cirrhosis an E pi thelitis: evidence of abnormal salivary gland Immunohistochemistry","volume":"26","author":"Tsuneyama","year":"1997","journal-title":"Autoimmunity"},{"issue":"1","key":"10.1016\/j.cld.2023.06.006_bib4","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1053\/j.gastro.2018.10.001","article-title":"Factors associated with recurrence of primary biliary cholangitis after liver transplantation and effects on graft and patient survival","volume":"156","author":"Montano-Loza","year":"2019","journal-title":"Gastroenterology"},{"issue":"4","key":"10.1016\/j.cld.2023.06.006_bib5","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1002\/hep.28641","article-title":"Chronic expression of interferon-gamma leads to murine autoimmune cholangitis with a female predominance","volume":"64","author":"Bae","year":"2016","journal-title":"Hepatology"},{"issue":"4","key":"10.1016\/j.cld.2023.06.006_bib6","doi-asserted-by":"crossref","first-page":"1408","DOI":"10.1002\/hep.29524","article-title":"The interplay of type I and type II interferons in murine autoimmune cholangitis as a basis for sex-biased autoimmunity","volume":"67","author":"Bae","year":"2018","journal-title":"Hepatology"},{"issue":"8594","key":"10.1016\/j.cld.2023.06.006_bib7","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1016\/S0140-6736(88)91894-6","article-title":"Primary biliary cirrhosis: identification of two major M2 mitochondrial autoantigens","volume":"1","author":"Yeaman","year":"1988","journal-title":"Lancet"},{"issue":"2","key":"10.1016\/j.cld.2023.06.006_bib8","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1055\/s-2007-979469","article-title":"Interpreting serological tests in diagnosing autoimmune liver diseases","volume":"27","author":"Invernizzi","year":"2007","journal-title":"Semin Liver Dis"},{"issue":"3","key":"10.1016\/j.cld.2023.06.006_bib9","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1002\/hep.23783","article-title":"Biliary apotopes and anti-mitochondrial antibodies activate innate immune responses in primary biliary cirrhosis","volume":"52","author":"Lleo","year":"2010","journal-title":"Hepatology"},{"issue":"3","key":"10.1016\/j.cld.2023.06.006_bib10","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1002\/hep.22736","article-title":"Apotopes and the biliary specificity of primary biliary cirrhosis","volume":"49","author":"Lleo","year":"2009","journal-title":"Hepatology"},{"issue":"2","key":"10.1016\/j.cld.2023.06.006_bib11","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/j.jaut.2008.05.003","article-title":"CD4 T-cell autoreactivity to the mitochondrial autoantigen PDC-E2 in AMA-negative primary biliary cirrhosis","volume":"31","author":"Shimoda","year":"2008","journal-title":"J\u00a0Autoimmun"},{"issue":"1","key":"10.1016\/j.cld.2023.06.006_bib12","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1084\/jem.20010956","article-title":"Identification of HLA-A2-restricted CD8(+) cytotoxic T\u00a0cell responses in primary biliary cirrhosis: T\u00a0cell activation is augmented by immune complexes cross-presented by dendritic cells","volume":"195","author":"Kita","year":"2002","journal-title":"J\u00a0Exp Med"},{"issue":"4","key":"10.1016\/j.cld.2023.06.006_bib13","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.1002\/hep.24526","article-title":"Fine phenotypic and functional characterization of effector cluster of differentiation 8 positive T\u00a0cells in human patients with primary biliary cirrhosis","volume":"54","author":"Tsuda","year":"2011","journal-title":"Hepatology"},{"key":"10.1016\/j.cld.2023.06.006_bib14","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.jaut.2016.12.012","article-title":"Chemokine receptor CXCR3 deficiency exacerbates murine autoimmune cholangitis by promoting pathogenic CD8+ T\u00a0cell activation","volume":"78","author":"Ma","year":"2017","journal-title":"J\u00a0Autoimmun"},{"issue":"2","key":"10.1016\/j.cld.2023.06.006_bib15","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1111\/j.1365-2249.2009.03898.x","article-title":"Imbalance between T helper type 17 and T regulatory cells in patients with primary biliary cirrhosis: the serum cytokine profile and peripheral cell population","volume":"156","author":"Rong","year":"2009","journal-title":"Clin Exp Immunol"},{"issue":"5","key":"10.1016\/j.cld.2023.06.006_bib16","doi-asserted-by":"crossref","first-page":"1944","DOI":"10.1002\/hep.26979","article-title":"IL-12\/Th1 and IL-23\/Th17 biliary microenvironment in primary biliary cirrhosis: implications for therapy","volume":"59","author":"Yang","year":"2014","journal-title":"Hepatology"},{"issue":"6","key":"10.1016\/j.cld.2023.06.006_bib17","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1111\/sji.12616","article-title":"Dysregulation of circulating Tfr\/Tfh ratio in primary biliary cholangitis","volume":"86","author":"Zheng","year":"2017","journal-title":"Scand J Immunol"},{"issue":"2","key":"10.1016\/j.cld.2023.06.006_bib18","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1002\/hep.27306","article-title":"CXCR5+ CD4+ T follicular helper cells participate in the pathogenesis of primary biliary cirrhosis","volume":"61","author":"Wang","year":"2015","journal-title":"Hepatology"},{"issue":"1","key":"10.1016\/j.cld.2023.06.006_bib19","doi-asserted-by":"crossref","first-page":"45","DOI":"10.2174\/156652409787314525","article-title":"Innate immunity and primary biliary cirrhosis","volume":"9","author":"Selmi","year":"2009","journal-title":"Curr Mol Med"},{"issue":"4","key":"10.1016\/j.cld.2023.06.006_bib20","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1111\/j.1478-3231.2006.01254.x","article-title":"Human intrahepatic biliary epithelial cells function in innate immunity by producing IL-6 and IL-8 via the TLR4-NF-kappaB and -MAPK signaling pathways","volume":"26","author":"Yokoyama","year":"2006","journal-title":"Liver Int"},{"issue":"2","key":"10.1016\/j.cld.2023.06.006_bib21","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1136\/jcp.2004.023507","article-title":"Interferon gamma accelerates NF-kappaB activation of biliary epithelial cells induced by Toll-like receptor and ligand interaction","volume":"59","author":"Harada","year":"2006","journal-title":"J\u00a0Clin Pathol"},{"issue":"1","key":"10.1016\/j.cld.2023.06.006_bib22","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1002\/hep.29418","article-title":"A\u00a0functional characteristic of cysteine-rich protein 61: modulation of myeloid-derived suppressor cells in liver inflammation","volume":"67","author":"Zhang","year":"2018","journal-title":"Hepatology"},{"issue":"8","key":"10.1016\/j.cld.2023.06.006_bib23","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1016\/j.dld.2013.01.005","article-title":"Apotopes and innate immune system: novel players in the primary biliary cirrhosis scenario","volume":"45","author":"Lleo","year":"2013","journal-title":"Dig Liver Dis"},{"issue":"4","key":"10.1016\/j.cld.2023.06.006_bib24","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1016\/j.jaut.2006.04.001","article-title":"Increased killing activity and decreased cytokine production in NK cells in patients with primary biliary cirrhosis","volume":"26","author":"Chuang","year":"2006","journal-title":"J\u00a0Autoimmun"},{"issue":"6","key":"10.1016\/j.cld.2023.06.006_bib25","doi-asserted-by":"crossref","first-page":"1817","DOI":"10.1002\/hep.28122","article-title":"Natural killer cells regulate T\u00a0cell immune responses in primary biliary cirrhosis","volume":"62","author":"Shimoda","year":"2015","journal-title":"Hepatology"},{"issue":"5","key":"10.1016\/j.cld.2023.06.006_bib26","doi-asserted-by":"crossref","first-page":"1118","DOI":"10.1016\/j.jhep.2015.12.017","article-title":"Biliary epithelium and liver B cells exposed to bacteria activate intrahepatic MAIT cells through MR1","volume":"64","author":"Jeffery","year":"2016","journal-title":"J\u00a0Hepatol"},{"issue":"1","key":"10.1016\/j.cld.2023.06.006_bib27","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1002\/hep.29782","article-title":"MAIT cells are chronically activated in patients with autoimmune liver disease and promote profibrogenic hepatic stellate cell activation","volume":"68","author":"B\u00f6ttcher","year":"2018","journal-title":"Hepatology"},{"issue":"6","key":"10.1016\/j.cld.2023.06.006_bib28","doi-asserted-by":"crossref","first-page":"1286","DOI":"10.1111\/jgh.14076","article-title":"Persistent reduction of mucosal-associated invariant T\u00a0cells in primary biliary cholangitis","volume":"33","author":"Setsu","year":"2018","journal-title":"J\u00a0Gastroenterol Hepatol"},{"issue":"10","key":"10.1016\/j.cld.2023.06.006_bib29","doi-asserted-by":"crossref","first-page":"3727","DOI":"10.1073\/pnas.1322778111","article-title":"Crystal structures of human soluble adenylyl cyclase reveal mechanisms of catalysis and of its activation through bicarbonate","volume":"111","author":"Kleinboelting","year":"2014","journal-title":"Proc Natl Acad Sci U\u00a0S\u00a0A"},{"issue":"2","key":"10.1016\/j.cld.2023.06.006_bib30","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1002\/hep.28550","article-title":"Soluble adenylyl cyclase regulates bile salt-induced apoptosis in human cholangiocytes","volume":"64","author":"Chang","year":"2016","journal-title":"Hepatology"},{"issue":"1","key":"10.1016\/j.cld.2023.06.006_bib31","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1002\/hep.22348","article-title":"Telomere shortening in the damaged small bile ducts in primary biliary cirrhosis reflects ongoing cellular senescence","volume":"48","author":"Sasaki","year":"2008","journal-title":"Hepatology"},{"issue":"2","key":"10.1016\/j.cld.2023.06.006_bib32","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1007\/s10620-013-2920-6","article-title":"Chemokine-chemokine receptor CCL2-CCR2 and CX3CL1-CX3CR1 axis may play a role in the aggravated inflammation in primary biliary cirrhosis","volume":"59","author":"Sasaki","year":"2014","journal-title":"Dig Dis Sci"},{"issue":"2","key":"10.1016\/j.cld.2023.06.006_bib33","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1016\/j.jhep.2010.03.008","article-title":"Modulation of the microenvironment by senescent biliary epithelial cells may be involved in the pathogenesis of primary biliary cirrhosis","volume":"53","author":"Sasaki","year":"2010","journal-title":"J\u00a0Hepatol"},{"issue":"3","key":"10.1016\/j.cld.2023.06.006_bib34","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1016\/j.jhep.2003.11.006","article-title":"Regulation of bile acid synthesis: pathways, nuclear receptors, and mechanisms","volume":"40","author":"Chiang","year":"2004","journal-title":"J\u00a0Hepatol"},{"issue":"1 Suppl","key":"10.1016\/j.cld.2023.06.006_bib35","doi-asserted-by":"crossref","first-page":"S25","DOI":"10.1016\/j.jhep.2015.02.023","article-title":"New paradigms in the treatment of hepatic cholestasis: from UDCA to FXR, PXR and beyond","volume":"62","author":"Beuers","year":"2015","journal-title":"J\u00a0Hepatol"},{"issue":"31","key":"10.1016\/j.cld.2023.06.006_bib36","doi-asserted-by":"crossref","first-page":"28857","DOI":"10.1074\/jbc.M011610200","article-title":"Human bile salt export pump promoter is transactivated by the farnesoid X receptor\/bile acid receptor","volume":"276","author":"Ananthanarayanan","year":"2001","journal-title":"J\u00a0Biol Chem"},{"issue":"4","key":"10.1016\/j.cld.2023.06.006_bib37","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1016\/S0022-2275(20)32398-1","article-title":"Peroxisome proliferator-activated receptor alpha (PPARalpha) and agonist inhibit cholesterol 7alpha-hydroxylase gene (CYP7A1) transcription","volume":"41","author":"Marrapodi","year":"2000","journal-title":"J\u00a0Lipid Res"},{"issue":"11","key":"10.1016\/j.cld.2023.06.006_bib38","doi-asserted-by":"crossref","first-page":"1840","DOI":"10.1161\/hq1101.098228","article-title":"Fibrates suppress bile acid synthesis via peroxisome proliferator-activated receptor-alpha-mediated downregulation of cholesterol 7alpha-hydroxylase and sterol 27-hydroxylase expression","volume":"21","author":"Post","year":"2001","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"35","key":"10.1016\/j.cld.2023.06.006_bib39","doi-asserted-by":"crossref","first-page":"32852","DOI":"10.1074\/jbc.M305361200","article-title":"Peroxisome proliferator-activated receptor alpha induces hepatic expression of the human bile acid glucuronidating UDP-glucuronosyltransferase 2B4 enzyme","volume":"278","author":"Barbier","year":"2003","journal-title":"J\u00a0Biol Chem"},{"issue":"20","key":"10.1016\/j.cld.2023.06.006_bib40","doi-asserted-by":"crossref","first-page":"17838","DOI":"10.1074\/jbc.M210634200","article-title":"Protective role of hydroxysteroid sulfotransferase in lithocholic acid-induced liver toxicity","volume":"278","author":"Kitada","year":"2003","journal-title":"J\u00a0Biol Chem"},{"issue":"3","key":"10.1016\/j.cld.2023.06.006_bib41","doi-asserted-by":"crossref","first-page":"1030","DOI":"10.1002\/hep.26894","article-title":"Peroxisome proliferator-activated receptor \u03b1 activates human multidrug resistance transporter 3\/ATP-binding cassette protein subfamily B4 transcription and increases rat biliary phosphatidylcholine secretion","volume":"59","author":"Ghonem","year":"2014","journal-title":"Hepatology"},{"issue":"10","key":"10.1016\/j.cld.2023.06.006_bib42","doi-asserted-by":"crossref","first-page":"578","DOI":"10.3858\/emm.2012.44.10.066","article-title":"Peroxisome proliferator-activated receptor \u03b4 agonist attenuates hepatic steatosis by anti-inflammatory mechanism","volume":"44","author":"Lee","year":"2012","journal-title":"Exp Mol Med"},{"issue":"4","key":"10.1016\/j.cld.2023.06.006_bib43","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1021\/jm990554g","article-title":"The PPARs: from orphan receptors to drug discovery","volume":"43","author":"Willson","year":"2000","journal-title":"J\u00a0Med Chem"},{"issue":"10","key":"10.1016\/j.cld.2023.06.006_bib44","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1080\/13543784.2022.2130750","article-title":"Seladelpar: an investigational drug for the treatment of early-stage primary biliary cholangitis (PBC)","volume":"31","author":"Wetten","year":"2022","journal-title":"Expert Opin Investig Drugs"},{"issue":"6","key":"10.1016\/j.cld.2023.06.006_bib45","doi-asserted-by":"crossref","first-page":"1344","DOI":"10.1016\/j.jhep.2021.01.013","article-title":"A\u00a0randomized placebo-controlled trial of elafibranor in patients with primary biliary cholangitis and incomplete response to UDCA","volume":"74","author":"Schattenberg","year":"2021","journal-title":"J\u00a0Hepatol"},{"issue":"6","key":"10.1016\/j.cld.2023.06.006_bib46","doi-asserted-by":"crossref","first-page":"3369","DOI":"10.1073\/pnas.051551698","article-title":"The nuclear receptor PXR is a lithocholic acid sensor that protects against liver toxicity","volume":"98","author":"Staudinger","year":"2001","journal-title":"Proc Natl Acad Sci U\u00a0S\u00a0A"},{"issue":"8","key":"10.1016\/j.cld.2023.06.006_bib47","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1016\/j.bbadis.2011.01.014","article-title":"Nuclear receptor PXR, transcriptional circuits and metabolic relevance","volume":"1812","author":"Ihunnah","year":"2011","journal-title":"Biochim Biophys Acta"},{"issue":"2","key":"10.1016\/j.cld.2023.06.006_bib48","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1016\/j.gastro.2005.05.009","article-title":"Complementary stimulation of hepatobiliary transport and detoxification systems by rifampicin and ursodeoxycholic acid in humans","volume":"129","author":"Marschall","year":"2005","journal-title":"Gastroenterology"},{"issue":"1","key":"10.1016\/j.cld.2023.06.006_bib49","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1006\/jaut.1999.0299","article-title":"Familial primary biliary cirrhosis in Hiroshima","volume":"13","author":"Tsuji","year":"1999","journal-title":"J\u00a0Autoimmun"},{"issue":"2","key":"10.1016\/j.cld.2023.06.006_bib50","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1053\/j.gastro.2004.05.005","article-title":"Primary biliary cirrhosis in monozygotic and dizygotic twins: genetics, epigenetics, and environment","volume":"127","author":"Selmi","year":"2004","journal-title":"Gastroenterology"},{"issue":"2","key":"10.1016\/j.cld.2023.06.006_bib51","doi-asserted-by":"crossref","first-page":"405","DOI":"10.3390\/genes14020405","article-title":"The genetics of primary biliary cholangitis: a GWAS and post-GWAS update","volume":"14","author":"Hitomi","year":"2023","journal-title":"Genes (Basel)"},{"issue":"2","key":"10.1016\/j.cld.2023.06.006_bib52","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1111\/j.1399-0039.1994.tb02303.x","article-title":"Genes within the HLA class II region confer both predisposition and resistance to primary biliary cirrhosis","volume":"43","author":"Begovich","year":"1994","journal-title":"Tissue Antigens"},{"issue":"1","key":"10.1016\/j.cld.2023.06.006_bib53","doi-asserted-by":"crossref","first-page":"11093","DOI":"10.1038\/s41598-017-11148-6","article-title":"Principal contribution of HLA-DQ alleles, DQB1\u221706:04 and DQB1\u221703:01, to disease resistance against primary biliary cholangitis in a Japanese population","volume":"7","author":"Yasunami","year":"2017","journal-title":"Sci Rep"},{"issue":"7","key":"10.1016\/j.cld.2023.06.006_bib54","doi-asserted-by":"crossref","first-page":"2483","DOI":"10.1053\/j.gastro.2021.02.061","article-title":"X\u00a0chromosome contribution to the genetic architecture of primary biliary cholangitis","volume":"160","author":"Asselta","year":"2021","journal-title":"Gastroenterology"},{"issue":"10","key":"10.1016\/j.cld.2023.06.006_bib55","doi-asserted-by":"crossref","first-page":"940","DOI":"10.1136\/gut.24.10.940","article-title":"Primary biliary cirrhosis: geographical clustering and symptomatic onset seasonality","volume":"24","author":"Hamlyn","year":"1983","journal-title":"Gut"},{"issue":"1","key":"10.1016\/j.cld.2023.06.006_bib56","doi-asserted-by":"crossref","first-page":"100202","DOI":"10.1016\/j.jhepr.2020.100202","article-title":"Geo-epidemiology and environmental co-variate mapping of primary biliary cholangitis and primary sclerosing cholangitis","volume":"3","author":"Dyson","year":"2020","journal-title":"JHEP Rep"},{"issue":"1","key":"10.1016\/j.cld.2023.06.006_bib57","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/j.jhep.2010.02.019","article-title":"Demographic, lifestyle, medical and familial factors associated with primary biliary cirrhosis","volume":"53","author":"Corpechot","year":"2010","journal-title":"J\u00a0Hepatol"},{"issue":"5","key":"10.1016\/j.cld.2023.06.006_bib58","doi-asserted-by":"crossref","first-page":"1194","DOI":"10.1002\/hep.20907","article-title":"Risk factors and comorbidities in primary biliary cirrhosis: a controlled Interview-based study of 1032 patients","volume":"42","author":"Gershwin","year":"2005","journal-title":"Hepatology"},{"issue":"2","key":"10.1016\/j.cld.2023.06.006_bib59","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1111\/cei.12224","article-title":"Escherichia coli infection induces autoimmune cholangitis and anti-mitochondrial antibodies in non-obese diabetic (NOD).B6 (Idd10\/Idd18) mice","volume":"175","author":"Wang","year":"2014","journal-title":"Clin Exp Immunol"},{"issue":"9","key":"10.1016\/j.cld.2023.06.006_bib60","doi-asserted-by":"crossref","first-page":"5874","DOI":"10.4049\/jimmunol.174.9.5874","article-title":"Chemical xenobiotics and mitochondrial autoantigens in primary biliary cirrhosis: identification of antibodies against a common environmental, cosmetic, and food additive, 2-octynoic acid","volume":"174","author":"Amano","year":"2005","journal-title":"J\u00a0Immunol"},{"issue":"2","key":"10.1016\/j.cld.2023.06.006_bib61","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1002\/hep.22390","article-title":"Loss of tolerance in C57BL\/6 mice to the autoantigen E2 subunit of pyruvate dehydrogenase by a xenobiotic with ensuing biliary ductular disease","volume":"48","author":"Wakabayashi","year":"2008","journal-title":"Hepatology"},{"issue":"1","key":"10.1016\/j.cld.2023.06.006_bib62","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.jaut.2006.06.002","article-title":"Identification of 2-nonynoic acid, a cosmetic component, as a potential trigger of primary biliary cirrhosis","volume":"27","author":"Rieger","year":"2006","journal-title":"J\u00a0Autoimmun"},{"issue":"5","key":"10.1016\/j.cld.2023.06.006_bib63","doi-asserted-by":"crossref","first-page":"1835","DOI":"10.1084\/jem.181.5.1835","article-title":"HLA DRB4 0101-restricted immunodominant T\u00a0cell autoepitope of pyruvate dehydrogenase complex in primary biliary cirrhosis: evidence of molecular mimicry in human autoimmune diseases","volume":"181","author":"Shimoda","year":"1995","journal-title":"J\u00a0Exp Med"},{"issue":"3\u20134","key":"10.1016\/j.cld.2023.06.006_bib64","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1016\/j.jaut.2009.02.022","article-title":"Primary biliary cirrhosis is associated with altered hepatic microRNA expression","volume":"32","author":"Padgett","year":"2009","journal-title":"J\u00a0Autoimmun"},{"issue":"19","key":"10.1016\/j.cld.2023.06.006_bib65","doi-asserted-by":"crossref","first-page":"e94416","DOI":"10.1172\/jci.insight.94416","article-title":"Microbiota, cirrhosis, and the emerging oral-gut-liver axis","volume":"2","author":"Acharya","year":"2017","journal-title":"JCI Insight"},{"issue":"10","key":"10.1016\/j.cld.2023.06.006_bib66","doi-asserted-by":"crossref","first-page":"3920","DOI":"10.1073\/pnas.0509592103","article-title":"Regulation of antibacterial defense in the small intestine by the nuclear bile acid receptor","volume":"103","author":"Inagaki","year":"2006","journal-title":"Proc Natl Acad Sci U\u00a0S\u00a0A"},{"issue":"6","key":"10.1016\/j.cld.2023.06.006_bib67","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1038\/cmi.2018.7","article-title":"The microbiome and autoimmunity: a paradigm from the gut-liver axis","volume":"15","author":"Li","year":"2018","journal-title":"Cell Mol Immunol"},{"key":"10.1016\/j.cld.2023.06.006_bib68","doi-asserted-by":"crossref","first-page":"1126117","DOI":"10.3389\/fimmu.2023.1126117","article-title":"Gut microbial profile of treatment-naive patients with primary biliary cholangitis","volume":"14","author":"Zhou","year":"2023","journal-title":"Front Immunol"},{"issue":"1","key":"10.1016\/j.cld.2023.06.006_bib69","doi-asserted-by":"crossref","first-page":"2208501","DOI":"10.1080\/19490976.2023.2208501","article-title":"Bacterial and metabolic phenotypes associated with inadequate response to ursodeoxycholic acid treatment in primary biliary cholangitis","volume":"15","author":"Martinez-Gili","year":"2023","journal-title":"Gut Microbes"},{"issue":"2","key":"10.1016\/j.cld.2023.06.006_bib70","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1016\/j.immuni.2013.08.013","article-title":"Gender bias in autoimmunity is influenced by microbiota","volume":"39","author":"Yurkovetskiy","year":"2013","journal-title":"Immunity"},{"issue":"6123","key":"10.1016\/j.cld.2023.06.006_bib71","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.1126\/science.1233521","article-title":"Sex differences in the gut microbiome drive hormone-dependent regulation of autoimmunity","volume":"339","author":"Markle","year":"2013","journal-title":"Science"},{"issue":"6","key":"10.1016\/j.cld.2023.06.006_bib72","doi-asserted-by":"crossref","first-page":"2522","DOI":"10.4049\/jimmunol.1400076","article-title":"Testosterone suppresses hepatic inflammation by the downregulation of IL-17, CXCL-9, and CXCL-10 in a mouse model of experimental acute cholangitis","volume":"194","author":"Schwinge","year":"2015","journal-title":"J\u00a0Immunol"},{"key":"10.1016\/j.cld.2023.06.006_bib73","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1186\/s12876-014-0189-7","article-title":"Intestinal permeability--a new target for disease prevention and therapy","volume":"14","author":"Bischoff","year":"2014","journal-title":"BMC Gastroenterol"},{"issue":"4","key":"10.1016\/j.cld.2023.06.006_bib74","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1046\/j.1365-2567.2003.01700.x","article-title":"Human secretory immunoglobulin A may contribute to biofilm formation in the gut","volume":"109","author":"Randal Bollinger","year":"2003","journal-title":"Immunology"},{"issue":"2","key":"10.1016\/j.cld.2023.06.006_bib75","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1111\/j.1572-0241.2002.05521.x","article-title":"Mucosal IgA defect in primary biliary cirrhosis","volume":"97","author":"Floreani","year":"2002","journal-title":"Am J Gastroenterol"},{"issue":"10266","key":"10.1016\/j.cld.2023.06.006_bib76","doi-asserted-by":"crossref","first-page":"1915","DOI":"10.1016\/S0140-6736(20)31607-X","article-title":"Primary biliary cholangitis","volume":"396","author":"Lleo","year":"2020","journal-title":"The Lancet"}],"container-title":["Clinics in Liver Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1089326123000806?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1089326123000806?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T18:01:47Z","timestamp":1761069707000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1089326123000806"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,2]]},"references-count":76,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2024,2]]}},"alternative-id":["S1089326123000806"],"URL":"https:\/\/doi.org\/10.1016\/j.cld.2023.06.006","relation":{},"ISSN":["1089-3261"],"issn-type":[{"value":"1089-3261","type":"print"}],"subject":[],"published":{"date-parts":[[2024,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Primary Biliary Cholangitis","name":"articletitle","label":"Article Title"},{"value":"Clinics in Liver Disease","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cld.2023.06.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}